France Proposes Axing Two Public Holidays to Tackle Deficit
The Dutch Intersection Is Coming to Save Your Life
Advocates Fear US Agents Are Using 'Wellness Checks' on Children as a Prelude to Arrests
LA Homelessness Drops for Second Year
Manhattan, Chicago Murder Rates Drop in 2025, Officials Say
The premier put forward the plans as he unveiled an array of measures amounting to €43.8 billion ($50.9 billion) to pare back the largest deficit in the euro area. Other moves include a new tax on the highest earners, a freeze in pension and welfare payments at 2025 levels, and possible sales of the state's stakes in companies.
Bayrou said the country is addicted to public spending and in 'mortal danger,' with debt increasing by €5,000 every second and interest costs on track to hit €100 billion per year in 2029 if nothing is done.
'This is the last stop before we hit the cliff and are crushed by debt,' he said in a speech in Paris. 'The entire nation must work harder to produce more and ensure that the country's overall activity is greater throughout the year.'
The government aims to narrow the budget gap to 4.6% of economic output in 2026 from a forecast 5.4% this year, before bringing it within the European Union's limit of 3% by 2029.
The sharp belt tightening Bayrou proposed represents a politically risky shift toward the kind of austerity policies undertaken by several other European countries, often during debt crises, but largely eschewed until now by successive French governments.
However, Bayrou may not be able to push through his plan. With no majority in parliament, the prime minister is in danger of being forced out in the fall through a no-confidence vote, the same fate that met his predecessor, Michel Barnier, in December.
The centrist premier is also under pressure from investors who have dumped French bonds over the last year amid deteriorating public finances and political uncertainty, driving up borrowing costs relative to peers.
On Tuesday, the yield premium on French 10-year bonds over German equivalents remained steady at around 70 basis points, close to the widest in three weeks.
Public Holidays
France has 11 public holidays a year, more than half of which are linked to Christian observance. That's the same as the number of federal holidays in the US in most years and compares with eight days off a year in England and Wales.
But as French schools and businesses sometimes shut on days between public holidays and weekends, the calendar can have an outsized impact on economic activity, particularly in May. Canceling two days would give a boost of 'several billion euros' to public finances, according to the prime minister.
'The problem is that French production is insufficient compared with our competitors,' Finance Minister Eric Lombard said on France 2 TV. 'The French on average work 100 hours less than the Germans.'
France wouldn't be the first European country to cut public holidays. Portugal suspended four of them in 2013 in an effort to boost economic output as part of a European bailout following a debt crisis. The government in Lisbon reversed that decision in 2016.
Bayrou said he would propose abolishing Easter Monday, which often lands in April, and May 8, which marks the victory of the allies over Nazi Germany.
Jordan Bardella, president of the National Rally, immediately rejected the move, calling it a 'direct attack on our history, our roots and working people' in a post on X. Marine Le Pen, who leads the far-right party in the National Assembly, said in a separate post that her group would propose to censure the government unless Bayrou revises his entire fiscal and economic plan.
Still, the premier could still survive a no-confidence vote if, like in February for the 2025 budget, he can convince some moderate left-wing lawmakers to abstain.
Boris Vallaud, the leader of the Socialist Party in the National Assembly, said on X that the budget plans are 'brutal and unacceptable.'
The Socialists will present their own proposals in the fall, the party said in a statement, adding that 'censure is the only prospect' for Bayrou's proposal.
France's lower house of parliament isn't scheduled to come back into session until late September.
For his part, Bayrou said the urgency of reining in France's deficit trumps any calculations about whether he could survive a no-confidence motion.
'This government knows perfectly well it is at the mercy of opposition' groups, he said, adding that there were even some doubts among parties that support him. 'But the government has the duty, the desire and the wish to overturn obstacles and give our country a reason to live and believe.'
--With assistance from James Hirai, Claudia Cohen and Phil Serafino.
(Updates with comment from Socialist Party in 18th paragraph.)
Forget DOGE. Musk Is Suddenly All In on AI
How Hims Became the King of Knockoff Weight-Loss Drugs
Thailand's Changing Cannabis Rules Leave Farmers in a Tough Spot
How Starbucks Is Engineering a Turnaround With Warm Vibes and Cold Foams
The New Third Rail in Silicon Valley: Investing in Chinese AI
©2025 Bloomberg L.P.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
8 minutes ago
- Yahoo
Democrats Schumer, Jeffries demand meeting with GOP to avert government shutdown
Sen. Chuck Schumer and Rep. Hakeem Jeffries Monday called on their Republican counterparts to meet immediately to avert a government shutdown looming as soon as the end of next month. The Democratic congressional leaders, both of whom are from New York, called on Senate Majority Leader John Thune, R-South Dakota, and Speaker Mike Johnson, R-Louisiana, to sit down this week to discuss a plan to pass next year's budget, which would normally require negotiation with the minority party to secure the 60 votes needed in the Senate to avoid a filibuster. 'We have the responsibility to govern for all Americans and work on a bipartisan basis to avert a painful, unnecessary shutdown at the end of September,' Schumer and Jeffries wrote. The Democratic leaders noted they are willing to work with Republicans on a bipartisan basis to negotiate a budget deal that would keep the government open past Sept. 30. But they accused President Donald Trump and GOP leaders of plotting to govern without any input from Democrats and shut down the government if they don't get their way. 'Many within your party are preparing to 'go it alone' and continue to legislate on a solely Republican basis,' the Democratic leaders wrote. Government funding will expire Sept. 30. Lawmakers say to prevent a shutdown Congress will likely need to pass a stopgap funding measure when lawmakers return to Washington, D.C., after Labor Day. In exchange for their cooperation in passing new budget measures, Democrats want Republicans to agree not to turn around later in the year and pass a rescissions package cutting some of that same funding. Republicans recently voted to claw back $9 billion in previously appropriated funding and defunded the Corporation for Public Broadcasting, taking advantage of the legislative loophole that rescissions only require a simple majority in the Senate, not a 60-vote bipartisan supermajority. Schumer and Jeffries are also pressing for the administration to release funding it has unilaterally held up even though it was allocated by Congress last year. Republicans have suggested they may seek to pass one or more policy bills before the midterm elections using the arcane reconciliation process, like they successfully did with Trump's One Big Beautiful Bill. That measure, which polls say is very unpopular with voters, enacted draconian cuts to health care spending to bankroll tax cuts for the wealthy and big corporations. _____
Yahoo
8 minutes ago
- Yahoo
Briumvi's Strong Sales Can't Stop TG Therapeutics Stock Slide
TG Therapeutics Inc. (NASDAQ:TGTX) stock is trading lower on Monday after the company reported worse-than-expected second-quarter 2025 earnings. What Happened TG Therapeutics reported second-quarter earnings per share of 17 cents, up from 4 cents a year ago, but below the consensus of 19 cents. The multiple sclerosis-focused company reported sales of $141.15 million, up from $73.5 million a year ago, missing the consensus of $146.42 the second quarter of 2025, Briumvi's U.S. net product revenue surged to $138.8 million, marking a significant 91% increase year-over-year and a 16% rise from the previous quarter. The drug's commercialization is also expanding globally with the company's partner, Neuraxpharm, with Briumvi now approved in the European Union, the United Kingdom, Switzerland, and Australia. Cash, cash equivalents and investment securities were $278.9 million as of June 30, 2025. TG Therapeutics anticipates that cash, cash equivalents, and investment securities as of June 30, 2025, combined with the projected revenues from Briumvi, will be sufficient to fund the business based on the current operating plan. Pipeline Development Patient enrollment was commenced in the randomized Phase 3 pivotal program to evaluate a consolidated Day 1 and Day 15 dosing regimen for IV Briumvi in the ongoing ENHANCE trial. View more earnings on TGTX The company has dosed the first patient with progressive multiple sclerosis in the Phase 1 clinical trial evaluating azer-cel for the treatment of autoimmune diseases. Guidance 'The strong uptake we're seeing, combined with deepening physician confidence and compelling patient experiences, underscores the strength of our launch strategy and gives us confidence in reaching our updated 2025 full year BRIUMVI U.S. net revenue guidance of $570 to $575 million,' said Michael Weiss, Chairman and CEO. TG Therapeutics raised its 2025 revenue outlook for Briumvi to a range of $570 million to $575 million, up from its previous guidance of $560 million. However, this is still below the consensus estimate of $596.12 million. TG Therapeutics raised fiscal 2025 Briumvi's U.S. net product revenue target to $570 million-$575 million from $560 million in prior guidance versus consensus estimate of $596.12 million. The company raised total global revenue target to approximately $585 million for the full year 2025 (prior guidance of $575 million for full year 2025). Price Action: TGTX stock is trading lower by 14.6% to $29.91 at last check Monday. Read Next:Photo by Piotr Swat via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Briumvi's Strong Sales Can't Stop TG Therapeutics Stock Slide originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
8 minutes ago
- Yahoo
Palantir Technologies Inc. (PLTR): A Bear Case Theory
We came across a bearish thesis on Palantir Technologies Inc. on Valueinvesting subreddit by smltc. In this article, we will summarize the bulls' thesis on PLTR. Palantir Technologies Inc.'s share was trading at $158.80 as as of July 25th. PLTR's trailing and forward P/E were 690.43 and 277.78, respectively according to Yahoo Finance. A software engineer manipulating a vast network of code on virtual monitors. Palantir Technologies has emerged as one of the most talked‑about names in the AI boom, with its data analytics platforms Gotham and Foundry, initially designed for intelligence agencies, now widely used by enterprises and governments. The company's newly launched AI platform enables natural‑language querying, further fueling investor excitement about its potential to dominate the AI‑driven data analytics space. Financial performance has been robust, with Q1 2025 revenue rising 39% year‑over‑year to $884 million, U.S. sales up 55%, and commercial revenue surging 71%. Palantir remains profitable, earning $462 million in 2024 and $214 million in the latest quarter, supported by $5.4 billion in cash reserves and no long‑term debt. Its customer base remains heavily skewed toward government contracts, contributing roughly 55% of revenue, and the top 20 clients account for a substantial share, creating concentration risk. Shares have soared more than 400% over the past year, closing around $159 on July 25, propelled by AI optimism. However, the valuation—trading at over 120× trailing sales and 200× next year's earnings—is historically extreme, implying that even modest growth disappointments could lead to steep declines. A discounted cash‑flow analysis, even with bullish assumptions, suggests fair value closer to $20–30 per share, in line with other fast‑growing software peers trading at 8–20× sales. Risks include intensifying competition from tech giants, reliance on large customers, potential government budget tightening, and shareholder dilution from heavy stock‑based compensation. While Palantir's fundamentals remain strong, analysts caution that exuberant pricing leaves little margin for error, making the stock a speculative bet despite its operational momentum. Previously we covered a bullish thesis on Palantir Technologies Inc. (PLTR) by Deep Value Returns in May 2025, which highlighted its strong growth, AI leadership, and profitable scaling despite a premium valuation. The company's stock has appreciated about 46% since, driven by AI optimism. smltc shares a contrarian view and emphasizes extreme valuation risks and downside potential. Palantir Technologies Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 77 hedge fund portfolios held PLTR at the end of the first quarter which was 64 in the previous quarter. While we acknowledge the potential of PLTR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None.